Hepatitis B Journal Articles

• Eight Weeks of Antiviral Therapy for Recent HCV Infection Is an 8-week therapy of paritaprevir/ritonavir/ombitasvir and dasabuvir + ribavirin as effective as the standard 12-week regimen in individuals with recent HCV infection?
  Journal of Viral Hepatitis, October 2018
• Risk Factors of HCC After HBsAg Seroclearance Which factors might increase risk of hepatocellular carcinoma among patients with chronic hepatitis B who have achieved seroclearance of hepatitis B surface antigen?
  Journal of Viral Hepatitis, October 2018
• A Pathway to Support GPs to Prescribe DAA Therapy for HCV This study describes an Australian program which enables general practitioners, via consultation with a specialist, to prescribe direct-acting antivirals to treat HCV.
  Journal of Viral Hepatitis, September 2018
• Vaccination Coverage Among Adolescents Aged 13-17 Years Is vaccination coverage among U.S. adolescents improving?
  Morbidity & Mortality Weekly Report, September 2018
• Association Between PPIs and Hepatocellular Carcinoma Might long-term use of proton pump inhibitors increase the risk of hepatocellular carcinoma?
  Alimentary Pharmacology & Therapeutics, September 2018
• Hepatitis B Virus and Risk of Non-Hodgkin Lymphoma Several prior studies have suggested that chronic HBV infection can increase the risk of non-Hodgkin's lymphoma. What's the current best evidence on this possible relationship?
  Journal of Viral Hepatitis, September 2018
• HIV: Ageing, Cognition and Neuroimaging at 4-Year Follow-Up What have we learned about the impact of HIV infection on neurocognitive ageing?
  HIV Medicine, September 2018
• Timing of HCV Therapy in Liver Transplant-Eligible Patients The authors developed a decision tree model to compare the cost-effectiveness of three strategies for timing of DAA treatment for HCV in liver transplant candidates.
  Journal of Viral Hepatitis, August 2018
• The Prevention of HBV-Related Hepatocellular Carcinoma This article discusses risk stratification of HBV-related hepatocellular carcinoma and summarizes three levels of preventive strategies.
  Alimentary Pharmacology & Therapeutics, August 2018
• Access to Treatment for HBV Infection -- Worldwide, 2016 Has increased availability of generic antivirals effective in treating chronic HBV infection improved access to treatment around the globe?
  Morbidity & Mortality Weekly Report, August 2018
• HBV Reactivation in HBV/HCV Co-infection Treated With DAAs This study explored the outcome of HBV infection in patients co-infected with HBV and HCV and treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.
  Journal of Viral Hepatitis, August 2018
• Risk Factors for Advanced Fibrosis After SVR in Chronic HCV This study investigated the long-term effect of achieved SVR on liver fibrosis in a cohort with pretreatment advanced chronic HCV infection. What risk factors are associated with persisting fibrosis?
  Journal of Viral Hepatitis, July 2018
• Efficacy of Generic Oral DAAs in Patients With HCV Infection Are generic oral direct-acting antivirals as effective against HCV as branded drugs in a real-life clinical situation?
  Journal of Viral Hepatitis, July 2018
• HCV Eradication by DAAs Improves Glucose Tolerance Chronic HCV genotype 1 is associated with a higher incidence of type 2 diabetes in its advanced stages. Could early HCV eradication improve glucose tolerance in patients with HCV-related cirrhosis?
  Liver International, July 2018
• Real-world Use of Elbasvir-Grazoprevir in Chronic HCV This retrospective analysis evaluated outcomes of hepatitis C patients treated with elbasvir-grazoprevir with or without ribavirin in clinical practice settings in the United States.
  Alimentary Pharmacology & Therapeutics, July 2018
• Twenty-Five Years of Lamivudine After 25 years, lamivudine continues to be recommended as part of ART regimens for HIV.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, June 2018
• Improving Linkage to Care Among Non-US Born Persons With HBV Seventy percent of persons in the US with chronic hepatitis B virus are non-US born. How well are we doing with providing hepatitis B testing and linkage-to-care programs to this population?
  Morbidity & Mortality Weekly Report, June 2018
• Incidence and Outcomes of Pregnancy-associated HBV Flares This study investigated the course of chronic HBV infection among pregnant women. What is the incidence of HBV flare during pregnancy and after delivery?
  Liver International, June 2018
• Liver Stiffness, Steatosis in HCV Patients With SVR on DAAs This study evaluated changes in liver stiffness and steatosis in patients with HCV who received direct-acting anti-viral therapy and achieved sustained virological response.
  Alimentary Pharmacology & Therapeutics, May 2018
• Estimating HCV Prognosis Using Transient Elastography Is non-invasive transient elastography as accurate as histologic assessment of fibrosis progression rates in estimating prognosis in treatment-naive chronic hepatitis C patients?
  Journal of Viral Hepatitis, May 2018